The current arsenal of antiviral agents available to the practitioner is expanding rapidly, such that by the time this article goes to press, new drugs may have already been added. Although the majority of approved drugs have been developed for use in only a few viral infections (eg, HIV, herpesviruses, and papillomavirus), discoveries made in the development of these drugs may lead to antiviral agents effective against other viruses. In addition, new uses for the currently available drugs are under evaluation. This review of antiviral agents discusses the treatments available for viral infections such as herpes simplex virus, varicella zoster virus, cytomegalovirus, human papillomavirus, chronic viral hepatitis, and others. (J Am Acad Dermatol 2002;47:581-99.)Le texte complet de cet article est disponible en PDF.
Abbreviations : CMG, EBV, FDA, HAART, HSV, IFN, MCV, TK, VZV
| Funding sources: None.
| Conflict of interest: None.
| Reprint requests: Stephen K. Tyring, MD, PhD, UTMB Center for Clinical Studies, Departments of Dermatology, Microbiology/Immunology and Internal Medicine, University of Texas Medical Branch, Route 1070, Galveston, TX 77555.